HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Isolinderalactone enhances the inhibition of SOCS3 on STAT3 activity by decreasing miR-30c in breast cancer.

Abstract
Development of an efficient treatment for triple-negative breast cancer is an urgent issues. Compounds from plant extracts are a potential source of novel cancer treatment. Isolinderalactone, a kind of sesquiterpenoids compound, was purified from the root of Lindera strychnifolia and Neolitsea daibuensis and shows anti-inflammatory and anticancer capacity. In the present study, isolinderalactone induced apoptosis in MDA-MB-231 cells which is a kind of triple-negative breast cancer cell line through induction of an intrinsic mitochondria-mediated and caspase-independent cell death. Treatment of isolinderalactone increased the protein level of the suppressor of cytokine signaling 3 (SCOS3), decreased phosphorylation of the signal transducer and activator of transcription 3 (STAT3), and suppressed expression of the down-stream genes of the X-linked inhibitor of apoptosis protein in MDA-MB-231 cells. Our results further showed that the level of SOCS3 expression was induced by isolinderalactone due to inhibiting the microRNA hsa-miR-30c-5p (miR-30c) expression. In addition, intraperitoneal injection of isolinderalactone induced apoptosis in a xenograft breast tumor while it did not significantly affect the histology of liver, kidney and lung of the treated mice. In conclusion, isolinderalactone induces apoptosis in MDA-MB‑231 cells and suppresses STAT3 signaling pathway through regulation of SOCS3 and miR-30c. It may become a novel treatment for triple-negative breast cancer in the future.
AuthorsMeng-Chi Yen, Ying-Chu Shih, Ya-Ling Hsu, En-Shyh Lin, Yi-Shiuan Lin, Eing-Mei Tsai, Ya-Wen Ho, Ming-Feng Hou, Po-Lin Kuo
JournalOncology reports (Oncol Rep) Vol. 35 Issue 3 Pg. 1356-64 (Mar 2016) ISSN: 1791-2431 [Electronic] Greece
PMID26707189 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • MIRN30b microRNA, human
  • MicroRNAs
  • SOCS3 protein, human
  • STAT3 Transcription Factor
  • STAT3 protein, human
  • Sesquiterpenes
  • Suppressor of Cytokine Signaling 3 Protein
  • Suppressor of Cytokine Signaling Proteins
  • X-Linked Inhibitor of Apoptosis Protein
  • XIAP protein, human
  • linderalactone
Topics
  • Animals
  • Apoptosis (drug effects)
  • Cell Proliferation (drug effects)
  • Female
  • Gene Expression Regulation, Neoplastic (drug effects)
  • Humans
  • Lindera (chemistry)
  • Mice
  • MicroRNAs (biosynthesis, genetics)
  • STAT3 Transcription Factor (biosynthesis, genetics)
  • Sesquiterpenes (administration & dosage)
  • Signal Transduction (drug effects)
  • Suppressor of Cytokine Signaling 3 Protein
  • Suppressor of Cytokine Signaling Proteins (biosynthesis, genetics)
  • Triple Negative Breast Neoplasms (drug therapy, genetics, pathology)
  • X-Linked Inhibitor of Apoptosis Protein (biosynthesis, genetics)
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: